Ernesto Sepulveda, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 33 Calle Victoria, Anasco, PR 00610 Phone: 787-826-6540 Fax: 787-826-6520 |
Servicios Optometricos Csp Optometrist Medicare: Medicare Enrolled Practice Location: Carr. #2, Edificio B , Multiplaza Pr, Suite #6 Bo. Caracol, Km. 143.3, Anasco, PR 00610 Phone: 787-826-6540 Fax: 787-826-6520 |
Dr. Mariem Rodriguez, OD Optometrist Medicare: Medicare Enrolled Practice Location: Plaza Salcedo, Suite 104, Anasco, PR 00610 Phone: 787-826-6484 Fax: 787-826-0215 |
Western Visual Care Psc Optometrist Medicare: Medicare Enrolled Practice Location: Carr 402 Km 4.6 Bo Pinales, Anasco, PR 00610 Phone: 787-203-7611 Fax: 787-229-1040 |
Optica Prisma Optometrist Medicare: Medicare Enrolled Practice Location: Pr 402 Km 2.9 Barrio Quebrada Larga, Valley Hills Professional Center Suite 11, Anasco, PR 00610 Phone: 787-918-1749 |
Dr. Ramon Edgardo Juan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: Carr 402 Km 4.6 Bo Pinales, Anasco, PR 00610 Phone: 787-203-7611 Fax: 787-229-1040 |
News Archive
Monitoring participants' biological clocks may be the quickest way to determine the effectiveness of experimental drugs currently under development to treat Angelman syndrome: a debilitating genetic disorder that occurs in more than one in every 15,000 live births.
Scientists at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital (Canada), European Molecular Biology Laboratory (Germany), and Massachusetts Institute of Technology (USA) have created a new computational method called NetworKIN.
A recent report by Centers for Disease Control (CDC) says that 80% of inspections of public aquatic venues in the United States found at least one violation of safety standards. Immediate closure is enforced on thousands of public pools, hot tubs, and water playgrounds in the US every year as a result of safety concerns.
Drawing heavily upon nature for inspiration, a team of researchers has created a new artificial lens that is nearly identical to the natural lens of the human eye. This innovative lens, which is made up of thousands of nanoscale polymer layers, may one day provide a more natural performance in implantable lenses to replace damaged or diseased human eye lenses, as well as consumer vision products; it also may lead to superior ground and aerial surveillance technology.
Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago